Web Stats Provided By Google Analytics

Wednesday, August 7, 2013

Bavarian Nordic Receives European Marketing Authorization for IMVANEX Smallpox Vaccine

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today! KVISTGAARD, Denmark, August 7, 2013 /PRNewswire/ -- In Phase 3 development in the U.S. under trade name IMVAMUNEA and supplied to the U.S. Strategic National Stockpile Bavarian Nordic A/S announced today that the European Commission has granted marketing ... (more)

http://www.biospace.com/news_story.aspx?StoryID=305182&full=1

No comments:

Post a Comment